CETRORELIX
- CAS No.
- 145672-81-7
- Chemical Name:
- CETRORELIX
- Synonyms
- Cetrorelix impurity;Ns 75a;D 20761;Ovurelix;Cetrotid;Sb 075 acetate;SB-075 ACETATE;NS-75A;Cetrorelix( x acetate);Cetrorelix acetate (SB-75);Cetrorelix Acetate, 10 mM in DMSO
- CBNumber:
- CB51478311
- Molecular Formula:
- C70H92ClN17O14.C2H4O2
- Molecular Weight:
- 1491.11
- MDL Number:
- MFCD08459466
- MOL File:
- 145672-81-7.mol
Product description | Number | Pack Size | Price |
Cetrorelix acetate ≥98% (HPLC) | C5249 | 5mg | $126.35 |
Cetrorelix acetate ≥98% (HPLC) | C5249 | 25mg | $503.5 |
Cetrorelix (acetate) ≥95% | 23910 | 1mg | $40 |
Cetrorelix (acetate) ≥95% | 23910 | 5mg | $99 |
Cetrorelix (acetate) ≥95% | 23910 | 10mg | $158 |
More product size |
storage temp. | -20°C |
---|---|
solubility | methanol: soluble10% |
form | solid |
color | White to off-white |
Water Solubility | Soluble in water |
Sequence | N-acetyl-{2-Naph-Ala}-{Cl-Phe}-{3Py-Ala}-Ser-Tyr-{Cit}-Leu-Arg-Pro-Ala-NH2 |
InChIKey | KFEFLCOCAHJBEA-YIQVFHPZNA-N |
NCI Dictionary of Cancer Terms | D-20761 |
FDA UNII | XPQ226310Q |
UNSPSC Code | 51111800 |
NACRES | NA.77 |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() GHS08 |
---|---|
Signal word | Danger |
Hazard statements | H360F |
Precautionary statements | P201-P280-P308+P313 |
Risk Statements | 60-63 |
Safety Statements | 22 |
WGK Germany | 3 |
CETRORELIX price More Price(16)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Sigma-Aldrich | C5249 | Cetrorelix acetate ≥98% (HPLC) | 145672-81-7 | 5mg | $126.35 | 2025-07-31 | Buy |
Sigma-Aldrich | C5249 | Cetrorelix acetate ≥98% (HPLC) | 145672-81-7 | 25mg | $503.5 | 2025-07-31 | Buy |
Cayman Chemical | 23910 | Cetrorelix (acetate) ≥95% | 145672-81-7 | 1mg | $40 | 2024-03-01 | Buy |
Cayman Chemical | 23910 | Cetrorelix (acetate) ≥95% | 145672-81-7 | 5mg | $99 | 2024-03-01 | Buy |
Cayman Chemical | 23910 | Cetrorelix (acetate) ≥95% | 145672-81-7 | 10mg | $158 | 2024-03-01 | Buy |
CETRORELIX Chemical Properties,Uses,Production
Description
Cetrorelix is a synthetic peptide antagonist of the gonadotropin-releasing hormone receptor (GnRHR) with a Kd value of 0.2 nM for radioligand binding to murine LTK- cells expressing human GnRHR. It inhibits the activation of hGnRHR and a downstream luciferase reporter gene in murine LTK- cells by the GnRHR agonist [D-Trp6]GnRH (IC50 = 1.2 nM). In vivo, cetrorelix (60 μg per day) reduces tumor volume to 35% of control and decreases serum luteinizing hormone levels by 50% in a human epithelial ovarian cancer mouse xenograft model. Centrorelix (0.5 mg/kg) protects the primordial follicles (PMF) in mouse ovaries from damage induced by cyclophosphamide with 65% to 86% PMF survival compared to 46% PMF survival with a saline control. Formulations containing cetrorelix have been used to prevent ovulation during in vitro fertilization.
Uses
Cetrorelix Acetate is an gonadotropin-releasing hormone antagonist and is used to treat hormone-sensitive cancers of the prostate and breast.
Uses
Cetrorelix, a luteinizing hormone releasing hormone receptor (LHRHR) antagonist, was used to study its safety, mechanism of action, metabolism, and efficacy as a therapeutic agent for the treatment of blood cancers such as multiple myeloma (MM). Cetrorelix is used to evaluate its effects on a wide range of physiological processes and malignancies that involve luteinizing hormone releasing hormone receptor signaling pathways involving processes such as steroidogenesis.
Definition
ChEBI: The acetic acid salt of cetrorelix. A gonadotrophin-releasing hormone (GnRH) antagonist, it is used for treatment of infertility and of hormone-sensitive cancers of the prostate and breast.
Biochem/physiol Actions
Cetrorelix acetate is a luteinizing hormone releasing hormone receptor antagonist. It causes prepubertal reduction in bone modeling, bone density and bone strength comparable to post-menopausal bone loss.
storage
Store at -20°C
References
[1] THOMAS BECKERS Peter H Helmut Reil?nder. Characterization of Gonadotropin-Releasing Hormone Analogs Based on a Sensitive Cellular Luciferase Reporter Gene Assay[J]. Analytical biochemistry, 1997, 251 1: Pages 17-23. DOI: 10.1006/abio.1997.2208
[2] T YANO. Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1994, 91 15: 7090-7094. DOI: 10.1073/pnas.91.15.7090
[3] DROR MEIROW. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice.[J]. Human reproduction, 2004, 19 6: 1294-1299. DOI: 10.1093/humrep/deh257
CETRORELIX Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD | +86-13017695106 +86-13676922317 | jiuyitime@fdachem.com | China | 16517 | 58 |
career henan chemical co | +86-0371-86658258 +8613203830695 | sales@coreychem.com | China | 29852 | 58 |
Shenzhen Nexconn Pharmatechs Ltd | +86-755-89396905 +86-15013857715 | admin@nexconn.com | China | 10406 | 58 |
BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19552 | 58 |
Cellmano Biotech Limited | 0551-65326643 18156095617 | info@cellmano.com | China | 995 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354; +17819995354 | marketing@targetmol.com | United States | 32434 | 58 |
Longyan Tianhua Biological Technology Co., Ltd | 0086 18039857276 18039857276 | CHINA | 2783 | 58 | |
HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6312 | 58 |
Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 | sales@sarms4muscle.com | China | 10473 | 58 |
InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6391 | 58 |
View Lastest Price from CETRORELIX manufacturers
Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
---|---|---|---|---|---|---|---|---|
![]() |
2025-10-13 | Cetrorelix Acetate
145672-81-7
|
US $2.00-5.00 / kg | 1kg | 99% | 100kg | ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD | |
![]() |
2025-09-17 | Cetrorelix Acetate
145672-81-7
|
US $40.00-123.00 / mg | 98.00% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2025-02-17 | Cetrorelix
145672-81-7
|
US $0.00-0.00 / box | 1box | 99% | 1000 | Shandong Huizhihan Supply Chain Co., Ltd |
-
- Cetrorelix Acetate
145672-81-7
- US $2.00-5.00 / kg
- 99%
- ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD
-
- Cetrorelix Acetate
145672-81-7
- US $40.00-123.00 / mg
- 98.00%
- TargetMol Chemicals Inc.
-
- Cetrorelix
145672-81-7
- US $0.00-0.00 / box
- 99%
- Shandong Huizhihan Supply Chain Co., Ltd